DAVID ALTSHULER - 15 Nov 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Global Research and CSO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
15 Nov 2022
Net transactions value
-$10,493
Form type
4
Filing time
17 Nov 2022, 15:08:51 UTC
Previous filing
09 Nov 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $10,493 -34 -0.09% $308.61 36,077 15 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.